Literature DB >> 20014755

Molecular modeling of two distinct triangular oligomers in amyloid beta-protein.

Jie Zheng1, Xiang Yu, Jingdai Wang, Jui-Chen Yang, Qiuming Wang.   

Abstract

Amyloid-beta (Abeta) peptides exhibit many distinct structural morphology at the early aggregate stage, some of which are biological relevant to the pathogenesis of Alzheimer's disease (AD). Atomic-resolution structures of the early Abeta aggregates and their conformational changes in amyloid aggregation remain elusive. Here, we perform all-atom molecular modeling and dynamics simulations to obtain two stable triangular-like Abeta structures with the lowest packing energy, one corresponding to the Tycko's model (Paravastu, A.; Leapman, R.; Yau, W.; Tycko, R. Proc. Nat. Acad. Soc. U.S.A. 2008, 105, 18349-18354) (referred to C-WT model) and the other corresponding to computational model (N-WT model). Both models have the same 3-fold symmetry but distinct beta-sheet organizations in which three Abeta hexamers pack together via either C-terminal beta-strand residues or N-terminal beta-strand residues forming distinct hydrophobic cross section. Structural and energetic comparisons of two 3-fold Abeta oligomers, coupled with structural changes upon the mutations occurring at the interacting interfaces, reveal that although hydrophobic interactions are still dominant forces, electrostatic interactions are more favorable in the N-WT model due to the formation of more and stable intersheet salt bridges, while solvation energy is more favorable in the C-WT model due to more exposed hydrophilic residues to solvent. Both models display many common features similar to other amyloid oligomers and therefore are likely to be biologically relevant.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20014755     DOI: 10.1021/jp907608s

Source DB:  PubMed          Journal:  J Phys Chem B        ISSN: 1520-5207            Impact factor:   2.991


  9 in total

Review 1.  Biochemistry of amyloid β-protein and amyloid deposits in Alzheimer disease.

Authors:  Colin L Masters; Dennis J Selkoe
Journal:  Cold Spring Harb Perspect Med       Date:  2012-06       Impact factor: 6.915

2.  Structural determination of Abeta25-35 micelles by molecular dynamics simulations.

Authors:  Xiang Yu; Qiuming Wang; Jie Zheng
Journal:  Biophys J       Date:  2010-07-21       Impact factor: 4.033

3.  The unique Alzheimer's β-amyloid triangular fibril has a cavity along the fibril axis under physiological conditions.

Authors:  Yifat Miller; Buyong Ma; Ruth Nussinov
Journal:  J Am Chem Soc       Date:  2011-02-07       Impact factor: 15.419

4.  Characteristics of amyloid-related oligomers revealed by crystal structures of macrocyclic β-sheet mimics.

Authors:  Cong Liu; Michael R Sawaya; Pin-Nan Cheng; Jing Zheng; James S Nowick; David Eisenberg
Journal:  J Am Chem Soc       Date:  2011-04-07       Impact factor: 15.419

5.  A Protocol for the Design of Protein and Peptide Nanostructure Self-Assemblies Exploiting Synthetic Amino Acids.

Authors:  Nurit Haspel; Jie Zheng; Carlos Aleman; David Zanuy; Ruth Nussinov
Journal:  Methods Mol Biol       Date:  2017

6.  Molecular interactions of Alzheimer amyloid-β oligomers with neutral and negatively charged lipid bilayers.

Authors:  Xiang Yu; Qiuming Wang; Qingfen Pan; Feimeng Zhou; Jie Zheng
Journal:  Phys Chem Chem Phys       Date:  2013-03-14       Impact factor: 3.676

7.  The conformational stability of nonfibrillar amyloid-β peptide oligomers critically depends on the C-terminal peptide length.

Authors:  Eileen Socher; Heinrich Sticht; Anselm H C Horn
Journal:  ACS Chem Neurosci       Date:  2014-02-11       Impact factor: 4.418

8.  Polymorphic structures of Alzheimer's β-amyloid globulomers.

Authors:  Xiang Yu; Jie Zheng
Journal:  PLoS One       Date:  2011-06-07       Impact factor: 3.240

9.  Role of the N-terminus for the stability of an amyloid-β fibril with three-fold symmetry.

Authors:  Christian A Söldner; Heinrich Sticht; Anselm H C Horn
Journal:  PLoS One       Date:  2017-10-12       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.